$149.9 Million
ESSA Pharma Inc.
Follow-On Offering
Active Bookrunner
$160.4 Million
Nurix Inc.
Follow-On Offering
Active Bookrunner
$140.0 Million
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
$114.9 Million
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
$57.0 Million
Oncorus, Inc.
Follow-On Offering
Active Bookrunner
$168.0 Million
Dyne Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$459.9 Million
Arvinas
Follow-On Offering
Active Bookrunner
$92.1 Million
Ocular Therapeutix, Inc.
Follow-On Offering
Active Bookrunner
$208.0 Million
ALX Oncology
Follow-On Offering
Active Bookrunner
$299.0 Million
Rocket Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.